The following table provides an overview of the latest patents of Revance Therapeutics, Inc. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP2490986Apr 24, 2024Methods And Systems For Purifying Non-Complexed Botulinum Neurotoxin1
EP3368071Jan 26, 2022Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic Effect1
EP2661276Aug 2, 2017Methods And Kits For Topical Application, Removal, And Inactivation Of Therapeutic Or Cosmetic Toxin Compositions1